Read + Share
Amedeo Smart
Independent Medical Education
Matsushita K, Marchandot B, Kibler M, Heger J, et al. P2Y12 inhibition by clopidogrel increases adverse clinical events after transcatheter aortic valve replacement. Int J Cardiol 2022 May 4. pii: S0167-5273(22)00583.PMID: 35525324
Email
LinkedIn
Facebook
Twitter
Privacy Policy